Mary Lynne Hedley, PhD
President and Co-founder, TESARO Inc., United States
XEOY Global Alumni Council Member 2018
XEY Entrepreneur Of The Year Australia Judge 2005, 2006, 2008
XEY World Entrepreneur Of The Year Judge and Coach 2011, 2014, 2015, 2016
Dr. Mary Lynne Hedley founded biopharmaceutical company TESARO, it has grown from 3 associates to nearly 700 employees on two continents and has achieved a market capitalization of more than US$6b.
She worked for a large pharmaceutical company before starting her own firm to focus on improving the quality of life for cancer patients. Since its inception, TESARO has brought two new drugs to the international market and has started clinical trials on several others.
The company focuses not just on oncology but also supportive care for cancer patients. It has developed treatments for ovarian cancer, as well as medicine to minimize the nausea and vomiting that is often a side effect of chemotherapy. Mary Lynne believe her success is due to creating and nurturing team members who achieve their professional potential and provide hope to patients and their families.